Related Experiment Videos
Pulmonary hypertension: diagnostics and therapeutics
1Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minn 55905, USA.
Mayo Clinic Proceedings
|June 14, 2000
Summary
Pulmonary hypertension (PH) screening involves noninvasive tests and considering various clinical issues. Treatment options range from prostacyclin to newer oral agents for PH management.
Area of Science:
- Cardiology
- Pulmonology
- Internal Medicine
Background:
- Pulmonary hypertension (PH) arises from diverse lung insults, sometimes with unknown causes.
- Effective screening for suspected PH relies on noninvasive tests like chest radiography, ECG, and echocardiography.
- Identifying common clinical problems associated with PH is crucial for diagnosis and management.
Purpose of the Study:
- To review noninvasive screening methods for pulmonary hypertension.
- To discuss common clinical conditions that should be considered in patients with PH.
- To outline current and investigational treatment options for pulmonary hypertension.
Main Methods:
- Review of noninvasive screening tests for pulmonary hypertension.
- Discussion of differential diagnoses for PH, including cardiac, pulmonary, and systemic conditions.
- Summary of pharmacologic treatments for PH, including established and emerging therapies.
Main Results:
- Noninvasive tests are effective for screening suspected pulmonary hypertension.
- Several common clinical conditions must be considered in the differential diagnosis of PH.
- Various treatment options are available, including prostacyclin and endothelin receptor antagonists.
Conclusions:
- Early and accurate screening for PH is essential.
- A comprehensive approach considering multiple clinical factors improves PH diagnosis.
- A range of treatment strategies exist for managing pulmonary hypertension.